Osteologix Holdings plc - OLGXF

Overview
Brokers

Osteologix Holdings plc develops pharmaceuticals for the treatment and prevention of diseases of bone and joint tissues. Its lead product candidate is NB S101, a novel dual acting bone agent for the treatment of osteoporosis. The company is based in Dublin, Ireland.

Trade Osteologix Holdings plc at these brokers

1 2 3 4 5 6 7 8 9 10

3.75

Platforms: Andriod App, iOS App, Mobile App, WebTrader
License: Not Applicable

Your capital is at risk

1 2 3 4 5 6 7 8 9 10

3.75

Platforms: Andriod App, Apple App, iOS App, MetaTrader 4, MetaTrader 5, Mobile App, Proprietary, WebTrader
License: CySEC, FCA UK

Your capital is at risk

1 2 3 4 5 6 7 8 9 10

4.5

Platforms: Andriod App, Apple App, iOS App, Mobile App, WebTrader
License: ASIC, CySEC, FCA UK

Your capital is at risk